Mounjaro

Mounjaro (Tirzepatide) is a prescription medication for type 2 diabetes and should only be used under the supervision of a healthcare provider. Possible side effects include nausea, diarrhea, and decreased appetite. Not suitable for individuals with a history of severe allergic reactions to any of its components. Consult your healthcare provider before starting Mounjaro, especially if you are pregnant, breastfeeding, or have other medical conditions. Always follow the prescribed dosage and administration instructions.

Before starting Mounjaro, consult your healthcare provider to ensure it is appropriate for you and obtain a prescription. Store Mounjaro in the refrigerator, and allow the pen to reach room temperature 30 minutes before use. Inspect the medication for particles or discoloration, and do not use it if it appears cloudy or contains particles. Choose an injection site on your abdomen, thigh, or upper arm, rotating sites with each injection. Clean the site with an alcohol swab, remove the pen cap, and follow the provided instructions for priming and dosing. Pinch the skin, insert the needle at a 90-degree angle, press the injection button, and hold until the dose is fully administered. Dispose of the needle in a sharps container and record the date and site of your injection. If you miss a dose, take it as soon as possible within the same day, or skip it if it's almost time for your next dose—never double the dose. Store unused pens in the refrigerator, away from direct light and heat, and once in use, pens can be kept at room temperature for up to 4 weeks. Contact your healthcare provider if you experience any adverse reactions or have questions about your medication, and always follow their specific instructions and the medication guide provided.

Active Ingredient:

• Tirzepatide: A dual GLP-1 and GIP receptor agonist used to improve blood sugar control in adults with type 2 diabetes.

Inactive Ingredients:

• Sodium Chloride: Used to maintain the appropriate salt balance in the solution.
• Sodium Phosphate Dibasic: Acts as a buffering agent to maintain the pH of the solution.
• Sodium Phosphate Monobasic: Another buffering agent to stabilize the pH.
• Mannitol: A sugar alcohol that helps to stabilize the solution.
• Hydrochloric Acid (for pH adjustment): Used to adjust the acidity of the solution.
• Sodium Hydroxide (for pH adjustment): Also used to balance the solution’s pH.
• Water for Injection: Sterile water used as a solvent to dissolve the active and inactive ingredients.

These ingredients combine to form a stable, effective, and injectable solution for the management of type 2 diabetes. Always refer to the medication guide for the most detailed and specific information.

Common Side Effects:

• Nausea
• Diarrhea
• Decreased appetite
• Vomiting
• Constipation
• Indigestion

Less Common Side Effects:

• Abdominal pain
• Fatigue
• Injection site reactions (e.g., redness, swelling, or itching)
• Gastroesophageal reflux disease (GERD)

Serious Side Effects:

• Severe allergic reactions (e.g., rash, itching/swelling, severe dizziness, trouble breathing)
• Pancreatitis (symptoms include severe stomach/abdominal pain, persistent nausea/vomiting)
• Kidney problems (e.g., changes in urine output)
• Gallbladder problems (e.g., gallstones, cholecystitis, symptoms include severe stomach pain, yellowing eyes/skin)
• Severe hypoglycemia (low blood sugar), especially if used with other diabetes medications

Note: This is not a complete list of possible side effects. If you experience any unusual symptoms or side effects, contact your healthcare provider immediately. Always consult your healthcare provider for more detailed information and guidance tailored to your specific health needs.

1. What is Mounjaro (Tirzepatide)? Mounjaro is a medication designed for adults with type 2 diabetes. It combines dual actions on GLP-1 and GIP receptors to help control blood sugar levels effectively.

2. How does Mounjaro work? Mounjaro works by enhancing insulin secretion and reducing glucose production in the liver, leading to more stable and controlled blood sugar levels.

3. How is Mounjaro administered? Mounjaro is administered as a once-weekly injection using a pre-filled, single-use pen for accurate and convenient dosing.

4. What are the benefits of using Mounjaro? Mounjaro offers significant benefits, including better blood sugar control, support for weight loss, and the convenience of a once-weekly injection.

5. Who can use Mounjaro? Mounjaro is intended for adults with type 2 diabetes who need better blood sugar control. Consult your healthcare provider to determine if it’s suitable for you.